In conclusion, our present results identified the novel discovery that PRMT5 clinically and functionally participates in lymph-node metastasis and proliferation of laryngeal carcinoma by enhancing the Wnt/β-catenin pathway. This evidence concerns the gene PRMT5 and laryngeal carcinoma.